glutathione reductase riboflavin deficiency and Apoptosis: A Review Flavin adenine dinucleotide (FAD) activates

J Endocrinol 222, R2538 (2014)

At present, no specific antihepatic fibrotic strategies exist, with antiviral therapy and the induction of the elimination of harmful factors being often used as conservative treatments to alleviate liver fibrosis

It is one of the twelve peptides the FDA removed from the list that restricted compounding in April 2026, and one of seven under formal advisory review on July 2324, 2026

The total human evidence base, as of this writing, consists of the following: 1) a Phase I safety trial of 42 healthy volunteers that was registered in 2015, canceled in 2016, and never published, 2) a retrospective case series of 12 patients with knee pain, no control group, and no validated outcome measure, and 3) a 2025 pilot safety study involving two healthy adults who received intravenous infusions at a single private clinic in Florida